Old Web
English
Sign In
Acemap
>
authorDetail
>
S Kolasinski
S Kolasinski
University of Pennsylvania
Medicine
Immunology
Rituximab
Rheumatology
Internal medicine
4
Papers
221
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
2008
Annals of the Rheumatic Diseases
Daniel A. Albert
Jonathan Dunham
Salar N. Khan
J Stansberry
S Kolasinski
Donald E. Tsai
Sally Pullman-Mooar
F Barnack
C Striebich
Rj Looney
E T Luning Prak
Robert P. Kimberly
Y Zhang
Robert A. Eisenberg
Show All
Source
Cite
Save
Citations (172)
An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus
2004
Arthritis Research & Therapy
Robert A. Eisenberg
S Khan
J Stansberry
Donald E. Tsai
S Kolasinski
E Rieder
Brian L. Kotzin
Rj Looney
C Strieber
Daniel A. Albert
Show All
Source
Cite
Save
Citations (1)
A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
2003
Arthritis Research & Therapy
Robert A. Eisenberg
Daniel A. Albert
J Stansberry
Donald E. Tsai
S Kolasinski
S Khan
Show All
Source
Cite
Save
Citations (11)
Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis
1996
Scandinavian Journal of Rheumatology
R. W. Levin
Park J
Barbara E. Ostrov
Antonio J. Reginato
Daniel Baker
J. S. Bomalaski
Michael A. Borofsky
M. Gardiner
Lawrence J. Leventhal
W. Louthrenoo
J. von Feldt
S Kolasinski
Schumacher Hr
Show All
Source
Cite
Save
Citations (37)
1